Cargando…
Transcriptome-Wide Analysis of RNA N(6)-Methyladenosine Modification in Adriamycin-Resistant Acute Myeloid Leukemia Cells
Acute myeloid leukemia (AML) is one of the most aggressive hematopoietic malignancies. Patients still suffer from refractory/relapsed disease after anthracycline-based therapy, which leads to a poor prognosis. N(6)-Methyladenosine (m(6)A) is the most abundant post-transcriptional modification in euk...
Autores principales: | Fang, Shu, Peng, Bo, Wen, Yanan, Yang, Jingjing, Wang, Hao, Wang, Ziwei, Qian, Kun, Wei, Yan, Jiao, Yifan, Gao, Chunji, Dou, Liping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9100953/ https://www.ncbi.nlm.nih.gov/pubmed/35571033 http://dx.doi.org/10.3389/fgene.2022.833694 |
Ejemplares similares
-
Functions of RNA N(6)-methyladenosine modification in acute myeloid leukemia
por: Zheng, Xue, et al.
Publicado: (2021) -
N6-Methyladenosine-Related lncRNAs Are Novel Prognostic Markers and Predict the Immune Landscape in Acute Myeloid Leukemia
por: Zhang, Lulu, et al.
Publicado: (2022) -
Comprehensive Analysis of N6-Methyladenosine-Related Long Noncoding RNA Prognosis of Acute Myeloid Leukemia and Immune Cell Infiltration
por: Zheng, Guowei, et al.
Publicado: (2022) -
Transcriptome-wide reprogramming of N(6)-methyladenosine modification by the mouse microbiome
por: Wang, Xiaoyun, et al.
Publicado: (2018) -
Epigenetic Modifications in Acute Myeloid Leukemia: Prognosis, Treatment, and Heterogeneity
por: Goldman, Samantha L., et al.
Publicado: (2019)